A concise, evidence-based medical tool that saves you money

Question:

Does the FDA approved drug Remdesivir lead to better clinical outcomes compared to ivermectin for COVID?

Answer:

No
MedHead Confidence Score: 4
Amount Saved: $3,000 cost of remdesivir compared to the cost of ivermectin post
Med-O-Meter

4

MedHead Message:

Yes, you heard that right. Remdesivir is FDA approved, and at over $3,000 per treatment, has no more clinical effectiveness than ivermectin in the latest Cochrane review. So, in other words, you can treat 100 people with ivermectin compared to one patient with remdesivir and have largely the same clinical effect. It is used in hospitals around the world every day for COVID treatment. Yet, it’s effectivness is not superior, and may actually be inferior to ivermectin outcomes. A message to all those who viciously attack a treatment that is almost certainly safe and dirt cheap, this is a warning shot across the bow: Don’t throw rocks if you live in a glass house.

References:

1. Ansems K, Grundeis F, Dahms K, Mikolajewska A, Thieme V, Piechotta V, Metzendorf M-I, Stegemann M, Benstoem C, Fichtner F. Remdesivir for the treatment of COVID‐19. Cochrane Database of Systematic Reviews 2021, Issue 8. Art. No.: CD014962. DOI: 10.1002/14651858.CD014962. Accessed 11 January 2022. 2. Popp M, Stegemann M, Metzendorf M-I, Gould S, Kranke P, Meybohm P, Skoetz N, Weibel S. Ivermectin for preventing and treating COVID‐19. Cochrane Database of Systematic Reviews 2021, Issue 7. Art. No.: CD015017. DOI: 10.1002/14651858.CD015017.pub2. Accessed 11 January 2022.

 

Become A MedHead Today!